Rv1694: tlyAMTB000019: rrs

Rv1694

More about Rv1694 on    TBDB.org

More about Rv1694 on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv1694: all mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Maus CE AAC 2005 CGA/TGA 7 3 Arg/STOP Published 2005 USA Sequencing Whole gene Cap Vio Cap 40ug/ml, Vio 20ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del C 26 - Frameshift Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 Feb CGG/TGG 40 14 Arg/Trp Published 2005 USA Sequencing Whole gene HRESEthKCapVioAmi K >80ug/ml Proportion method 16/18 1/0 Also mutated at rrs A1401G. -
Maus CE AAC 2005 CGA/TGA 52 18 Arg/STOP Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 CAG/TAG 64 22 Gln/STOP Published 2005 USA Sequencing Whole gene Cap Cap 40ug/ml, Vio <10ug/ml Proportion method 30/30 3/0 None identified specifically. -
Maus CE AAC 2005 del A 23 - Frameshift Published 2005 USA Sequencing Whole gene RESKCapVio Ami Cap 80ug/ml Proportion method 18/18 1/0 None found in region analyzed. -
Maus CE AAC 2005 Feb del GCC 67-69 23 del A Published 2005 USA Sequencing Whole gene HRESKCapVioAmi K 20ug/ml Proportion method 16/18 1/0 None found in region analyzed. -
Maus CE AAC 2005 GCG/GAG 200 67 Ala/Glu Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 AAA/GAA 205 69 Lys/Glu Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 ins C 218 - Frameshift Published 2005 USA Sequencing Whole gene HRESKCapVioAmi Cap 80ug/ml Proportion method 18/18 1/0 None found in region analyzed. -
Maus CE AAC 2005 GCA/GAA 272 91 Ala/Glu Published 2005 USA Sequencing Whole gene Cap Cap 40ug.ml, Vio <10ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del G 310 - Frameshift Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 CTG/CCG 353 118 Leu/Pro Published 2005 USA Sequencing Whole gene CapVio Cap 40ug/ml, Vio 40ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 GTG/GAG 383 128 Val/Glu Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 ins C 397 - Frameshift Published 2005 USA Sequencing Whole gene CapVio Cap 40ug/ml, Vio 20ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del A 400 - Frameshift Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 Feb CTG/CCG 449 150 Leu/Pro Published 2005 USA Sequencing Whole gene HRSCap K <5ug/ml Cap 40ug/ml Proportion method 16/18 0/1 None found in region analyzed. -
Maus CE AAC 2005 del G 477 - Frameshift Published 2005 USA Sequencing Whole gene Cap Cap 40ug/ml, Vio <10ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 C/T 548 183 Pro/Leu Published 2005 USA Sequencing Whole gene CapVio Cap 40ug/ml, Vio 20ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 C/T 550 184 Gln/STOP Published 2005 USA Sequencing Whole gene Cap Cap 40ug/ml, Vio <10ug/ml Proportion method 30/30 5/0 None identified specifically. -
Maus CE AAC 2005 T/G 555 185 Phe/Leu Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del G 586 - Frameshift Published 2005 USA Sequencing Whole gene CapVio Cap 40ug/ml, Vio 20ug/ml Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del T 653 - Frameshift Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 Feb ins C - 218 Frameshift Published 2005 USA Sequencing Whole gene HRESKCapVioAmI K 20ug/ml Proportion method 16/18 1/0 None found in region analyzed. -
Maus CE AAC 2005 del GT 673-674 - Frameshift Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 Feb AAT/AAG 708 236 Asn/Lys Published 2005 USA Sequencing Whole gene HSCapVio K <5ug/ml Cap 80ug/ml Proportion method 16/18 0/1 None found in region analyzed. -
Maus CE AAC 2005 G/A 712 238 Glu/Lys Published 2005 USA Sequencing Whole gene Cap N.S. Proportion method 30/30 1/0 None identified specifically. -
Maus CE AAC 2005 del C 758 - Frameshift Published 2005 USA Sequencing Whole gene CapVio Cap 40ug/ml, Vio 20ug/ml Proportion method 30/30 1/0 None identified specifically. -

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator